Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Edwards Lifesciences Corporation
Edwards Lifesciences Corporation News
Edwards Lifesciences Corporation Quantitative Score
About Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Edwards Lifesciences Corporation Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
Edwards Lifesciences Corporation Financials
Table Compare
Compare EW metrics with: | |||
|---|---|---|---|
Earnings & Growth | EW | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | EW | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | EW | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | EW | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Edwards Lifesciences Corporation Income
Edwards Lifesciences Corporation Balance Sheet
Edwards Lifesciences Corporation Cash Flow
Edwards Lifesciences Corporation Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Neutral |
| Return on Equity | Buy |
| Return on Assets | Strong Buy |
| Debt/Equity Ratio | Neutral |
| Price/Earnings Ratio | Strong Sell |
| Price/Book Ratio | Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Historical Market Cap
Shares Outstanding
Edwards Lifesciences Corporation Executives
| Name | Role |
|---|---|
| Bernard J. Zovighian | Chief Executive Officer & Director |
| Jean-Luc Lemercier | Corporate Vice President of Japan, Asia Pacific & Greater China |
| Scott Ullem | Corporate VP & CFO |
| Donald E. Bobo Jr. | Corporate Vice President of Strategy & Corporate Development |
| Daveen Chopra | Corporate Vice President of Transcatheter Mitral & Tricuspid Therapies |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Bernard J. Zovighian | Chief Executive Officer & Director | Male | 1968 | 2.68M |
| Jean-Luc Lemercier | Corporate Vice President of Japan, Asia Pacific & Greater China | Male | 1957 | 1.43M |
| Scott Ullem | Corporate VP & CFO | Male | 1967 | 1.37M |
| Donald E. Bobo Jr. | Corporate Vice President of Strategy & Corporate Development | Male | 1962 | 1.37M |
| Daveen Chopra | Corporate Vice President of Transcatheter Mitral & Tricuspid Therapies | Male | 1979 | 1.24M |
Edwards Lifesciences Corporation Insider Trades
| Date | 12 Dec |
| Name | BOBO DONALD E JR |
| Role | CVP,Strategy/Corp Development |
| Transaction | Disposed |
| Type | S-Sale |
| Shares | 5486.1175 |
| Date | 12 Dec |
| Name | BOBO DONALD E JR |
| Role | CVP,Strategy/Corp Development |
| Transaction | Disposed |
| Type | S-Sale |
| Shares | 5900 |
| Date | 12 Dec |
| Name | BOBO DONALD E JR |
| Role | CVP,Strategy/Corp Development |
| Transaction | Disposed |
| Type | G-Gift |
| Shares | 7100 |
| Date | 12 Dec |
| Name | Lippis Daniel J. |
| Role | CVP, JAPAC |
| Transaction | Acquired |
| Type | M-Exempt |
| Shares | 1019 |
| Date | 12 Dec |
| Name | Lippis Daniel J. |
| Role | CVP, JAPAC |
| Transaction | Disposed |
| Type | S-Sale |
| Shares | 1019 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 12 Dec | BOBO DONALD E JR | CVP,Strategy/Corp Development | Disposed | S-Sale | 5486.1175 |
| 12 Dec | BOBO DONALD E JR | CVP,Strategy/Corp Development | Disposed | S-Sale | 5900 |
| 12 Dec | BOBO DONALD E JR | CVP,Strategy/Corp Development | Disposed | G-Gift | 7100 |
| 12 Dec | Lippis Daniel J. | CVP, JAPAC | Acquired | M-Exempt | 1019 |
| 12 Dec | Lippis Daniel J. | CVP, JAPAC | Disposed | S-Sale | 1019 |